0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Policy & Risk Sign in to save

Size-dependent toxicity of polystyrene microplastics in lung cells: An in vivo and in vitro study

Ecotoxicology and Environmental Safety 2025 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 53 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Xiaoshan Zhu, Zhi‐Liang Chu, Pengfei Xie, Deshan Chen, Deshan Chen, Xin Liu, Huijuan Chen, Reza Heidari, Mohammad Mehdi Ommati, Hui Gong, Ping Sun

Summary

Researchers investigated the size-dependent toxicity of polystyrene microplastics in lung cells using both mouse and cell culture models. The study found that smaller 1-micrometer particles accumulated more in lung tissue than larger particles and identified epithelial-mesenchymal transition as a key toxic mechanism, driven by ECM-MMP signaling cascades that contribute to lung injury.

Polymers
Body Systems
Models
Study Type In vivo

Microplastics (MPs) are emerging pollutants with pervasive respiratory exposure routes, yet their lung-specific toxicity mechanisms remain poorly defined. This study aims to investigate the size-dependent detrimental effects on pulmonary systems using in vivo (mice) and in vitro (coculture) models, simulating acute (single dose) and subchronic (28-day) exposures. Crucially, we identify epithelial-mesenchymal transition (EMT) as a novel cytotoxic mechanism and delineate the ECM-MMP signaling cascade as the primary driver of PS-MP-induced lung injury. In vivo, acute intratracheal exposure to 12 mg/kg PS-MPs (with 1 µm particles) resulted in weight loss (9.09 % vs. controls). PS-MPs accumulated dominantly in lungs, with 1 µm particles depositing 1.38-fold higher than 10 µm particles (quantitative result). Subchronic exposure (8 mg/kg) triggered particle-size-dependent pathology. 1 µm PS-MPs increased lung injury scores by 2.5-fold vs. 10 µm. Myeloperoxidase (MPO) and malondialdehyde (MDA) rose by 2.13-fold (1 µm) vs. 1.81-fold (10 µm). In vitro, 1 µm PS-MP-exposed lung cells induced mitochondrial depolarization (ΔΨm loss: 50 %) and apoptosis (17 % increase). Critically, 1 µm PS-MPs potently activated MMPs (MMP-2↑180 %, MMP9↑250 %) via ECM-MMP dysregulation. Our findings reveal that PS-MPs drive lung injury through oxidative stress, cell apoptosis, and mitochondrial dysfunction in a strict size-dependent manner (1 µm > 5 µm > 10 µm), with the ECM-MMP axis as a central pathway. The signaling pathway activated by PS-MPs in lung injury suggested that PS-MPs induced proliferation inhibition, oxidative stress, and EMT via activating the ECM-MMP signaling cascade. In addition, EMT activation suggested a novel mechanism for the cytotoxicity of PS-MPs, hinting at the potential carcinogenic effect of these pollutants.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Microplastics and nanoplastics, emerging pollutants, increased the risk of pulmonary fibrosis in vivo and in vitro: A comparative evaluation of their potential toxicity effects with different polymers and size

Researchers compared the lung toxicity of microplastics and nanoplastics made from polystyrene, polyethylene, and polypropylene in mice and human lung cells. They found that all particle types induced signs of pulmonary fibrosis, inflammation, and tissue remodeling, with polystyrene nanoplastics causing the most severe effects. The study suggests that smaller nanoplastic particles and certain polymer types may pose greater risks to lung health.

Article Tier 2

Unveiling the Pulmonary Toxicity of Polystyrene Nanoplastics: A Hierarchical Oxidative Stress Mechanism Driving Acute–Subacute Lung Injury

Researchers investigated the pulmonary toxicity of polystyrene nanoplastics smaller than 100 nm in lung epithelial cells and macrophages, finding that exposure triggered a hierarchical oxidative stress mechanism that drove acute to subacute lung injury through lipid peroxidation and inflammation.

Article Tier 2

Toxic effects of nanoplastics with different sizes and surface charges on epithelial-to-mesenchymal transition in A549 cells and the potential toxicological mechanism

Researchers exposed human lung cells to polystyrene nanoplastics of different sizes and surface charges and found they triggered a process called epithelial-to-mesenchymal transition, which is associated with the early stages of lung fibrosis. Smaller particles and those with positive surface charges caused the strongest effects, activating oxidative stress and inflammatory pathways. The study suggests that inhaled nanoplastics could contribute to respiratory health risks by promoting tissue scarring in the lungs.

Article Tier 2

Size-Dependent PulmonaryToxicity and Whole-Body Distributionof Inhaled Micro/Nanoplastic Particles in Male Mice from Chronic Exposure

Researchers used a whole-body inhalation exposure system to chronically expose male mice to polystyrene micro- and nanoplastics at environmental concentrations and tracked particle distribution and lung toxicity. Nanoplastics (80 nm) showed greater tissue transport than microplastics (1 µm), with highest accumulation in lungs followed by blood and spleen, and both sizes disrupted oxidative balance and antioxidant defenses.

Article Tier 2

Bioaccumulation of differently-sized polystyrene nanoplastics by human lung and intestine cells

Researchers examined how human lung and intestine cells take up polystyrene nanoplastics of different sizes, finding that smaller particles were internalized in greater numbers but at lower total mass compared to larger ones. When compared on a surface area basis, the uptake rates were similar across sizes, suggesting that surface interactions with cell membranes play a key role. The findings indicate that particle size is an important factor to consider when evaluating the health risks of nanoplastic exposure.

Share this paper